Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman Reply

Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman Reply

The authors respond to a letter by Mitchell Berger in the March‐April 2024 issue of the Hastings Center Report concerning their essay “Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.”

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Hastings Center report 2024-03, Vol.54 (2), p.44-45
Hauptverfasser: Rand, Leah Z., Carpenter, Daniel P., Kesselheim, Aaron S., Bhaskar, Anushka, Darrow, Jonathan J., Feldman, William B.
Format: Artikel
Sprache:eng
Schlagworte:
bioethics
FDA
Freedom of Information Act
noninterference
revolving door
Trade Secret Act
transparency
trustworthiness
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors respond to a letter by Mitchell Berger in the March‐April 2024 issue of the Hastings Center Report concerning their essay “Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.”
ISSN:0093-0334
1552-146X
DOI:10.1002/hast.1579